Johns Hopkins Technology Ventures
Overview
Johns Hopkins Technology Ventures (JHTV) is the commercialization and entrepreneurship hub of the university, responsible for fostering a rich innovation ecosystem and bringing Johns Hopkins discoveries to market. JHTV aims to maximize the impact of Johns Hopkins University's research excellence by facilitating the translation and commercialization of discoveries into accessible technologies, products and services that benefit society.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Myocardial Solutions | Jun 2016 | Series A | Co-investor |
| AuraSense | Mar 2023 | Accelerator | Co-investor |
| Kubanda Cryotherapy | Oct 2024 | Seed | Co-investor |
| Delfi Diagnostics | Jan 2021 | Series A | - |
| Nacuity Pharmaceuticals, Inc. | Jan 2019 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Michelle Lai
Smart Cookies Nutrition Program Founder
Mindi Levin
Founder And Director, JHU SOURCE
Ona Ambrozaite
Co-Founder Johns Hopkins Science Diplomacy Hub JHU Bloomberg Center Washington, D.C.
Ulviyya Huseynli
Founder And President Of Azerbaijan Student Association
Akshay Mani
Managing Director - Center For Digital Health
Jennifer Dimitri
Managing Director, Investment Operations
Kimberly Scott
Managing Director
Michelle Kim
Managing Director Of The RNA Innovation Center
Quyet Tran
Managing Director
Christine Ewan
Associate Vice President For Principal Gifts
Giovanna Maria Dora Dore
Associate Professor And EAS Director - Krieger School Of Arts And Sciences TR Track
Lindsay Kubaryk
Director Of Principal Gifts Strategy Fund For Johns Hopkins Medicine
Mary Burke
Director Of Principal Gifts
Brandon Fonder
Principal Owner
Dan Stutman
Principal Research Scientist
Danielle Solis
Principal Gifts Officer
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Johns Hopkins Technology Ventures based?
Johns Hopkins Technology Ventures is headquartered in Baltimore, Maryland, United States.
When was Johns Hopkins Technology Ventures founded?
Johns Hopkins Technology Ventures was founded in 2014.
How many portfolio companies does Johns Hopkins Technology Ventures have?
Johns Hopkins Technology Ventures has 8 portfolio companies in Caplight's dataset.
What are some companies in Johns Hopkins Technology Ventures's portfolio?
Portfolio companies visible on Caplight include Myocardial Solutions, AuraSense, Kubanda Cryotherapy, Delfi Diagnostics, Nacuity Pharmaceuticals, Inc..
What was Johns Hopkins Technology Ventures's most recent investment shown here?
Johns Hopkins Technology Ventures's most recent investment in this portfolio sample was in Kubanda Cryotherapy in 2024.
What sectors does Johns Hopkins Technology Ventures focus on?
Johns Hopkins Technology Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Johns Hopkins Technology Ventures focus on?
Johns Hopkins Technology Ventures typically invests at the Early stage.
What is Johns Hopkins Technology Ventures's AUM?
Johns Hopkins Technology Ventures's assets under management are estimated between $250.0M and $500.0M.